Author

Topic Search

Topic Options

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 15 2009 at 11:31pm

CDC: Injectable Swine Flu Vaccines Ready

http://www.youtube.com/watch?v=ge7YWKsS3do&feature=related

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 17 2009 at 8:32pm

my take on..

Week 40 ending October 10, 2009

Week 40
.....................
..............................
........................................

Counting ...all... Influenza ...like Illness ... high in some areas of the the Nation.
..............................................................................................................................

13,921 specimens
4,093   Influenza Type A (all types)
       15           "           "    B
..............................................

9,813    Felt like Flu ... but it was something else. Perhaps we should look into a "cure"

61.4% of positive Flu A cases were ... 2009 H1N1v 2,505 cases (proir week 1,549)

(38.2%) A (subtyping not performed) 1,556 cases

(0.4%) A (unable to subtype) 17 cases

"..rare sporadic cases of oseltamivir resistant 2009 influenza A (H1N1) viruses have

been detected worldwide, including 13 cases in the United States ..."

Cases Of Influenza Like Illness For All Regions
....................................................................................

Highest

............

Region 6 AR, LA, NM, OK, TX

High

........

Region 4
AL, FL, GA, KY, MS, NC, SC, TN

Region 10
AK, ID, OR, WA

Moderate
.................

Region 7
IA, KS, MO, NE

Region 9
AZ, CA, HI, NV

Fair
.......

Region 3
DE, DC, MD, PA, VA, WV

Region 8
CO, MT, ND, SD, UT, WY

Low
........

Region 1
CT, ME, MA, NH, RI, VT

Region 2
NJ, NY

Region 5
IL, IN, MI, MN, OH, WI

See Region Graphs here-
http://www.cdc.gov/flu/weekly/regions2008-2009/hhssenusmap.htm
.......................................................................................................................................

....................................................................

observed proportion of deaths
attributed to pneumonia or influenza
...................................................................

"epidemic threshold," i.e., the point at which the observed proportion of deaths
attributed to pneumonia or influenza was significantly higher than would be expected at
that time of the year ...

for week 38.... (the) percentage
was below
..................
the epidemic threshold of 6.4%.

for week 39 was ......   at the epidemic threshold of 6.5%

For week 40.............    above the epidemic threshold of 6.5% f

source... FluView
http://www.cdc.gov/h1n1flu/updates/us/
http://www.cdc.gov/flu/weekly/

...........................

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 18 2009 at 7:59pm

Reporters need to do the homework :)

Does the New York Times Have A Medical/Health Reporter?
........................................................................................................

Article here-
http://www.nytimes.com/2009/10/16/health/16vaccine.html

Swine Flu Shots Revive a Debate About Vaccines

By JENNIFER STEINHAUER
Published: October 15, 2009

.....................................................................................................................................

"the vaccine"

Is this Reporter unaware? ... of the many different companies and methods of antigen

preperation that make up several varieties of 'the vaccine?'

Newly formed? is that a code for... new technology?

Quickly distributed? you betcha..

Fast tracked into becoming a .. normal strain change...for future vaccine...smooth move.

............................

The most common complaint is that the vaccine

has been newly formed

and quickly distributed

without the benefit of clinical trials; in fact, the swine flu vaccine was made using the same

techniques as seasonal flu shots over the last two decades,

(does this Reporter know what clinical trials are? Dosage and..... Safety? )

and

a small number of clinical trials

were conducted this year

to determine the

adequate dose.

.................................................

(that's not > safety trials )

in fact, the swine flu vaccine was made using the same

techniques as seasonal flu shots over the last two decades,

( yes that one vaccine... ) "The Vaccine" made using the same techniques...

cell technology... with human, animal and Insects...they want tio try ...plants.

Could the Reporter tell us why they were termed "experimental vaccines?"

Working on experimental vaccines for decades? oh... that's ok then...

...............

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 19 2009 at 7:29pm

This shows us that errors are made in Dosage.... Please... check the Dosage for your child.

Know the Name of the vaccine given and the Name of the Manufacturer.

Then Look at the file to see what the dosage is... write it down or copy it off.

Take it with you ... or call the school and ask questions.

The time is worth it :)

..................

DOSAGE ERRORS

..........................

Vaccine Problems

http://www.medalerts.org/vaersdb/findfield.php?EVENTS=on&PAGENO=33&PERPAGE=10&ESORT=&VAX=(FLUN)

VAERS ID:	229930	Vaccination Date:	2004-10-26
Age:	25.0	Onset Date:	2004-10-26 Days later: 0
Gender:	Female	Submitted:	2004-10-28
State:	Maryland	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: NONE

Preexisting Conditions:

CDC 'Split Type': MEDI0002350

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500336P	0	IN

Administered by: Other Purchased by: Other

Symptoms: Medication error

Write-up: This is a non serious spontaneous case from a nurse of a medication error. The reporter causality was not provided to Flumist. A nurse reported a series of medication errors. The nurse misunderstood the dosing instructions for FluMist and administered a double dose of vaccine to seven pt's . Prior to the administration of the vaccine she removed the dose divider clip thereby giving 0.50ml per nostril versus the prescribed dose of 0.25 ml per nostril. On 26Oct04, at 4:00 in the afternoon, the reporter gave a double dose of FluMist to a 25 year old female pt whose medical history was not reported. The reporter stated the pt had no adverse events. No further information is available.

VAERS ID:	229931	Vaccination Date:	2004-10-26
Age:	41.0	Onset Date:	2004-10-26 Days later: 0
Gender:	Female	Submitted:	2004-10-28
State:	Maryland	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: NONE

Preexisting Conditions:

CDC 'Split Type': MEDI0002351

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500336P	0	IN

Administered by: Other Purchased by: Other

Symptoms: Medication error

Write-up: This is a non serious spontaneous case from a nurse of a medication error. The reporter causality was not provided to Flumist. A nurse reported a series of medication errors. The nurse misunderstood the dosing instructions for FluMist and administered a double dose of vaccine to seven pt's . Prior to the administration of the vaccine she removed the dose divider clip thereby giving 0.50ml per nostril versus the prescribed dose of 0.25 ml per nostril. On 26Oct04, at 12:00 in the afternoon, the reporter gave a double dose of FluMist to a 41 year old female pt whose medical history was not reported. The reporter stated the pt had no adverse events. No further information is available.

VAERS ID:	229932	Vaccination Date:	2004-10-26
Age:	47.0	Onset Date:	2004-10-26 Days later: 0
Gender:	Female	Submitted:	2004-10-28
State:	Maryland	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: NONE

Preexisting Conditions:

CDC 'Split Type': MEDI0002352

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500336P	0	IN

Administered by: Other Purchased by: Other

Symptoms: Medication error

Write-up: This is a non serious spontaneous case from a nurse of a medication error. The reporter causality was not provided to Flumist. A nurse reported a series of medication errors. The nurse misunderstood the dosing instructions for FluMist and administered a double dose of vaccine to seven pt's . Prior to the administration of the vaccine she removed the dose divider clip thereby giving 0.50ml per nostril versus the prescribed dose of 0.25 ml per nostril. On 26Oct04, at 11:00 in the morning, the reporter gave a double dose of FluMist to a 47 year old female pt whose medical history was not reported. The reporter stated the pt had no adverse events. No further information is available.

VAERS ID:	229933	Vaccination Date:	2004-10-26
Age:	34.0	Onset Date:	2004-10-26 Days later: 0
Gender:	Female	Submitted:	2004-10-28
State:	Maryland	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: NONE

Preexisting Conditions:

CDC 'Split Type': MEDI0002353

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500336P	0	IN

Administered by: Other Purchased by: Other

Symptoms: Medication error

Write-up: This is a non serious spontaneous case from a nurse of a medication error. The reporter causality was not provided to Flumist. A nurse reported a series of medication errors. The nurse misunderstood the dosing instructions for FluMist and administered a double dose of vaccine to seven pt's . Prior to the administration of the vaccine she removed the dose divider clip thereby giving 0.50ml per nostril versus the prescribed dose of 0.25 ml per nostril. On 26Oct04, at 10:00 in the morning, the reporter gave a double dose of FluMist to a 34 year old female pt whose medical history was not reported. The reporter stated the pt had no adverse events. No further information is available.

VAERS ID:	229934	Vaccination Date:	2004-10-28
Age:	38.0	Onset Date:	2004-10-29 Days later: 1
Gender:	Female	Submitted:	2004-11-01
State:	Texas	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: NONE

Preexisting Conditions: NONE

CDC 'Split Type': MEDI0002362

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500333P	0	IN

Administered by: Other Purchased by: Private

Symptoms: Headache, Rhinorrhoea

Write-up: This is a not serious spontaneous case from a pharmacist of headache. The reporter causality is not provided to FluMist. A health professional reported headache, runny nose, nasal and head congestion after receiving her first dose of FluMist on 28Oct04. On the morning of 29Oct04 the reporter stated she had a headache, runny nose, and congestion. The reporter took ibuprofen for treatment and had some relief. The symptoms continue. No further information is available.

VAERS ID:	229935	Vaccination Date:	2004-10-21
Age:	50.0	Onset Date:	2004-10-22 Days later: 1
Gender:	Female	Submitted:	2004-11-01
State:	California	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: NONE

Preexisting Conditions: NONE

CDC 'Split Type': MEDI0002364

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500335P		IN

Administered by: Other Purchased by: Private

Symptoms: Cough, Eye irritation, Laryngitis, Pharyngolaryngeal pain, Rhinorrhoea

Write-up: This is a non serious spontaneous case from a pharmacist of Burning Sensation in Eye. The reporter causality was not provided to FluMist. A pharmacist reported loss of voice, sore throat, runny nose, cough, the burning sensation in the left nostril, and eye area in a 50 year old female after receiving her first FluMist dose on 21Oct04. The reporter would not disclose the pt's history or contact information. On 26Oct04 the pt stated to the reporter that one day after receiving FluMist she had a burning sensation in her left nostril. She also had a runny nose and congestion which subsided by 29Oct04. On 29Oct04 the pt complained of cough, sore throat and loss of voice. The burning sensation in her nostril remained and had spread to her eye area. No further information is available.

VAERS ID:	229936	Vaccination Date:	2004-11-02
Age:	49.0	Onset Date:	2004-11-03 Days later: 1
Gender:	Male	Submitted:	2004-11-11
State:	Tennessee	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? No

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: Cholesterol Medication

Preexisting Conditions: NONE

CDC 'Split Type': MEDI0002401

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN50033P	0	IN

Administered by: Other Purchased by: Other

Symptoms: Headache

Write-up: This is a not serious spontaneous case from a pharmacist of throbbing head. The reporter causality is not provided to FluMist. A pharmacist reported the complaint of a throbbing in the head in a 49 year old pt one day after receiving FluMist. The pt received FluMist on 02Nov04 at 8:30AM. The reporter stated the pt's head throbbing started at an unspecified time on 03Nov04 and has continued for almost a week. The pt's head would throb in five minute episodes.

VAERS ID:	229937	Vaccination Date:	2004-11-04
Age:	51.0	Onset Date:	2004-11-06 Days later: 2
Gender:	Female	Submitted:	2004-11-16
State:	North Carolina	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? Yes

ER or Doctor Visit? No

Hospitalized? No

Current Illness:

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: Allergy Med

Preexisting Conditions: Pollen Allergy, allergy shots within 4 weeks of receiving FluMist.

CDC 'Split Type': MEDI0002435

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC			IN

Administered by: Private Purchased by: Other

Symptoms: Influenza like illness

Write-up: This is a non serious spontaneous case from a physician who reports a pt experienced influenza like symptoms after receiving FluMist. The reporter did not provide causality between events and FluMist. A female pt experienced flu like symptoms within 48 hours of receiving FluMist IN (date unknown). The pt recovered one week after the start of the events. The reporter did not provide causality between event and FluMist vaccination. Follow up 03/07/05: Lot number for vaccine not recorded.

VAERS ID:	229938	Vaccination Date:	2004-11-08
Age:	42.0	Onset Date:	2004-11-11 Days later: 3
Gender:	Female	Submitted:	2004-11-18
State:	Texas	Entered:	2004-12-02

Life Threatening Illness? No

Died? No

Disability? No

Recovered? Yes

ER or Doctor Visit? No

Hospitalized? No

Current Illness: Methicillin resistant, staphylococcal culture

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: Flonase, Prozac, Klonopin, Birth control pills, Guaifenesin

Preexisting Conditions: S. aureus carrier, methicillin resistant, staphylococcus aureus (MRSA), past disease: endocarditis.

CDC 'Split Type': MEDI0002440

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	IN500337P		IN

Administered by: Private Purchased by: Private

Symptoms: Ageusia, Anosmia, Pharyngolaryngeal pain, Sinusitis

Write-up: This is a not serious spontaneous case from a consumer involving loss of smell. The reporter causality is not related to FluMist. A 41 year old female reported the loss of smell, loss of taste, and a sore throat three days after receiving one dose of FluMist. This female with the history of MRSA (Methicillin Resistant Staphylococcus aureus) infection and endocarditis received FluMist on 08Nov04 at 5:00PM. She had taken one dose of fluticasone propionate on the morning of 08Nov04. Her physician instructed her to discontinue the use of fluticasone propionate for one week after receiving FluMist. On 11Nov04 by 6:00PM, the reporter was not able to smell or taste anything. On 15Nov04, around lunch the reporter regained the ability to smell and taste without intervention. She stated on 15Nov04 she had a mild sore throat that she believed was due to sinus drainage. On 16Nov04 the reporter continued fluticasone propionate usage. She stated that the events were due to the discontinuance of the fluticasone propionate. No further information available.

VAERS ID:	229961	Vaccination Date:	2004-11-19
Age:	48.0	Onset Date:	2004-11-20 Days later: 1
Gender:	Female	Submitted:	2004-12-03
State:	Maryland	Entered:	2004-12-03

Life Threatening Illness? No

Died? No

Disability? No

Recovered? Yes

ER or Doctor Visit? No

Hospitalized? No

Current Illness: none

Diagnostic Lab Data:

Previous Vaccinations:

Other Medications: none

Preexisting Conditions: none

CDC 'Split Type':

Vaccination	Manufacturer	Lot	Dose	Route	Site
FLUN	MEDIMMUNE, INC./WYETH LABORATORIES, INC	500340P	0	IN

Administered by: Unknown Purchased by: Unknown

Symptoms: Ear pain, Feeling hot, Myalgia, Nasal congestion, Pyrexia, Urticaria

Write-up: Symptoms developed the morning of 11/20/04 and lasted until 11/23/04. Pt c/o congestion, earache, muscle aches and low grade fever. Pt developed hives on Saturday afternoon. Pt reports taking Benadryl and the hives subsided 1 hour later. Pt reports hives reoccurred on Sunday am 11/21/04 and again subsided after taking Benadryl. Pt reports feeling "heat" behind knees and on elbows which lasted approx. 2 hours. Pt reports that symptoms

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 22 2009 at 1:34pm

Mary008's take ... on..

Senate Hearing on "H1N1 Flu: Monitoring the Nation's Response"
Wednesday

Due to delays in production, health officials announced that between 28 and 30 million doses of H1N1 vaccine will be delivered by the end of the month, as opposed to the expected 40 million. Secretaries Napolitano (DHS), Sebelius (HHS) & Duncan (Education) testified on this and other issues before the Senate Homeland Security Cmte.

http://www.c-span.org/Watch/Media/2009/10/21/HP/A/24522/Senate+Hearing+on+H1N1+Flu+Monitori

ng+the+Nations+Response.a

spx

Dept. Of HomeLand Security is in Charge... Health and Human services is Leading the medical.

H1N1 is widespread.

2,300 people have died in the country since April. (abt 6 months)

Highly Infective.

pediatric deaths are ... mentioned as from H1N1... but it is>>> All Influenza Like Illness

28 deaths of pregnant women (very sad..). ...but out of 300 million is >>very low.

Then they go on to talk about the vaccine... not enough. (heaven help us if they roll out

the experimental vaccine... because of "quiet desparation" )

Then the senator talks about Bioterrorism...

27 states could exceed hospital bed capacity...

Numbers fly around... (almost as if everyone in a state could all become ill at the same

time... :/ Wild thought.)

Barda Program... farsighted... breakthrough antivirals by intervenous application... have

not completed all the trials... used via FDA's compasionate usage authorization.

(If you ask me 30% of the country ....is becoming infected... and we are not seeing a lot of

deaths as yet...good news....effecting most mildly... questioning if it will get ahead of

our capacity to deal with it.)

(During the summer Wisconsin ..and NY state were... highly infected... and they dealt

with it....( near by states are ready to assist eachother with resources.)

Millions of Americans are worried about the vaccine.

Gov. bought 250 million doses...

(but not all of those purchased were conventional

egg basesed vaccine)

40 million were to be available... 25% fewer doses than

projected...

(Did the Govt. know what they were purchasing? ie... how 'experimental'

some of the the vaccines are? ... I think not)

She (senator) says she is interested on hearing about the shortage of the vaccine...

Janet Napolitano... is addressing the committee... Dept of Homeland sec....is the lead

Coordinater HSPD5... is the lead for HSPD5 ....Dept of Health and Human services and

CDC... lead on vaccine... planning assumed there would be a gap between the flu

spiking and vaccine availability. ...Simple actions...washing hands and coughing

properly help slow the transmission of this virus.

Since April.. planning.... prep and response... mission critical ... etc...etc....

Fema reviewed ...planning during a pandemic...business of the country...

... software updates on picture of H1N1... daily... Training teams...for states that say...

we need help... Robust system of communicating.... (but) ....not at a local and state

level...lessons learned... ongoing meetings... surge before vaccine available.. keep

critical infrastructure going...steps Companies can take... Mexico...Canada... working

with them... reviewing Emergency info...we will work our way through this...vaccine

would not be commonly available...Vaccine addressed by Sebilious... 3 billion shared for

hospital surge planning... planning for care outside hospitals...

Health and Human Services...

Secretary Sebelius... speaks... vaccine...

science based advice... situational updates twice a week... (?) .... flu.gov...5 million hits

a week.... we have some good news ...virus has not changed significantly since April...

More illness than in a typical flu season.... 86 lab confirmed pediatric H1N1 deaths

since April... 1/2 of Flu Like Hopitalizations are are under age 25.

(small percentage) Deaths... 90% people under 65 ....90% over 65 is usual...

Intensely monitoring the world... (still waiting to hear about vaccine shortage)

Vaccination program is underway... production is slower... in context... identified in

April...has a robust vaccine.... 5 producers of vaccine...11 million doses ordered by

states... 150,000 sites where vaccine is automatically delivered.... We are relying on

their numbers...... early delays due to 2 issues...

antigen yielding lower results than anticipated...yields more robust now...new

production lines...glitches...fill and finish... corrected....number growing ....by early

November vaccine will be more widely available... there is enough vaccine and will

be ....

lessons we've learned....too dependant on vaccine production in other countries...we are

using old technology...we are still still using egg based technology ...

we are committed

to developing cell basedand newer technology....very focused on that....cell technology

we need to make all aspects of the vaccine manufacturing process more appropriate for

the 21st century ... very focused on that....safety is essential.... lingering questions....

taken enough time for clinical trials?....This vaccine is being made the way seasonal flu

vaccine is made... excelleration of production of antiviral... scientists will lead our

recommendations.... coughing and sneezing etc etc... Seseme St... Elmo.... YouTube...

getting the message out.

..................

..... Unplannned closure (of schools) lead to loss of meals...income of parents...kids

home alone...good hygene...decks further apart...new school dismissal system...

Schools should not close unless there is a Magnitude... of personnel and teachers ill....
....................................................................................................................................................

Comment
.........................

Used NY as an example of less school closures in fall...

stating the number closed in spring as compared to the number open in the fall...

(there is little flu in NYS this fall )

(My take is...Because the flu illness is fairly moderate in over 99% of the population.. it

is better to keep the schools open unless massive numbers are ill because it is too

disruptive to close them.... they are hoping for herd immunity through

vaccination...hoping it will move ahead of the spread of the disease)

The demand is ahead.... of the yield... (of traditionally produced vaccine?)

Only one of the 5 producers of the vaccines..... is in the US. (Sanofi in Sweetwater PA)

(have to go out....more later)

real quick...senator is asking if...vaccine is going to be too late to protect people...

Sec Sebelius says ...

even if you had it in the spring or fall...get the vaccine (scientists encourage)

....As different strains develope ...it will likely immunise them for what is to come.

What kind of amazing vaccine is this?

............

have a look at the video... thoughts?

Mahshadin

Admin Group

Joined: January 26 2006
Location: United States
Status: Offline
Points: 2627

Post Options

Post Reply

Quote Mahshadin

Thanks(0)

Quote

Posted: October 22 2009 at 4:56pm

Wow Maryoo8 that is extremely detailed info on the vaccines

Thanks

"In a time of universal deceit, telling the truth is a revolutionary act." G Orwell

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 23 2009 at 11:23am

senator is asking if...vaccine is going to be too late to protect people...

Sec Sebelius says ...

even if you had it in the spring or fall...get the vaccine (scientists encourage)

....As different strains develope ...it will likely immunise them for what is to come.

What kind of amazing vaccine is this?

............

Infection with a virus of one subtype confers little or no protection against viruses of other

subtypes. {02} {05} Furthermore, over time, antigenic variation (antigenic drift) within a

subtype may be so marked that infection or vaccination with one strain may not induce

immunity to distantly related strains of the same subtype. {02} {05}

{2}
Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations

of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996; 45(RR-5): 1-24.

{5}
Centers for Disease Control and Prevention (CDC). Prevention and control of influenza: recommendations

of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46(RR-9): 1-25.

...........................................

Does that seem conflicting to anyone?

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 23 2009 at 1:55pm

Novartis Fluvirin...Info... lets people know that...

Immunocompromised persons may have a reduced immune response to Influenza A

(H1N1) 2009 monovalent vaccine.

That means... If you had your spleen removed or ar otherwised deemed

immunocompromised by your Doctor... you may have a reduced immune response

to the (H1N1) 2009 monovalent vaccine.

So ... discuss with your Doctor ... other ways you can protect yourself.

................................................................................................................

Other conditions, such as certain cancers and genetic disorders, can also cause a person

to become immunocompromised. Immunocompromised individuals can sometimes be prone

to more serious infections and/or complications than healthy people. They are also more

prone to getting opportunistic infections, which are infections that do not normally afflict

healthy individuals.

Causes for Immunodeficiency:
....................................................

Genetic - inherited genetic defects

Acquired - infections, such as HIV, and certain cancers, including leukemia, lymphoma, or multiple myleoma

Chronic diseases - such as end stage renal disease and dialysis, diabetes, cirrhosis

Medications - such as steroids, chemotherapy, radiation, immunosuppressive post-transplant medications

Physical State - such as pregnancy

It is important to note that not all immunodeficiencies result in the same risk for infection.

................

Patients who undergo splenectomy (removal of the spleen)

are at increased risk for infection.

The spleen acts as a filter and manufactures important antibodies (components of

immune system that fight specific antigens [infectious agents]).

sources for above-

http://www.novartis.com/newsroom/media-releases/en/2009/1345850.shtml

www.stjude.org/stjude/v/index.jsp?vgnextoid

http://infectiousdiseases.about.com/od/glossary/g/immunocompromised.htm

..................

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 23 2009 at 10:16pm

Line%20Charts%20of%20Percentage%20of%20Visits%20for%20Influenza-like%20Illness%20%28ILI%29%20Reported%20by%20
the%20U.S.%20Outpatient%20Influenza-like%20Illness%20Surveillance%20Network%20%28ILINet%29

Posted: 30 September 2009 at 11:25pm

Region 5.

Is something odd in the drawing above?

Has anyone noticed it does not match the summer severity shown in the Region 5 graph below?

Region 5 had about twice the summer flu that was seen in New York, which is region 2.

The second Mountain above should be higher than the first, it isn't

INFLUENZA ISOLATES FROM THE HHS REGION V (IL, IN, MI, MN, OH, WI)
Reported By WHO/NREVSS Collaborating Laboratories
2008-2009 Season

%20Region%20Chart%20of%20Influenza%20Positive%20Tests%20Reported%20to%20CDC%20by%20U.S.%20WHO/NREVSS%20Collaborating%20Laboratories

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 23 2009 at 10:23pm

Here is New York over the summer Region 2

Look at ther numbers along the sides of the graph for NY & NJ here...and compare the numbers to the graph above.

INFLUENZA ISOLATES FROM THE HHSREGION 2 (NJ, NY)
Reported By WHO/NREVSS Collaborating Laboratories
2008-2009 Season

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 24 2009 at 12:56am

Thank you to Elver for this link....

Gary Null Speaking Out at the NYS Assembly Hearing (10-13-2009) - Zoi Florosz (Cameras) | Gabriel Amauru (Video Editor/Motion Artist) | Steve Long (Video Editor) | Bing Thoven (Audio Design) | Richard Polonetsky (Producer) | Gary Null (Director/Executive Producer)

There are 3 videos. The links to the other 2 are on the right.

http://www.youtube.com/user/GaryNullTV#p/a/964B3E6C0465D14C/0/y3XlJB7J5-o

.......................

GlaxoSmithKline

Pandemrix

...........................

There are no data on administration of AS03-adjuvanted vaccines before or following other

types of influenza vaccines intended for pre-pandemic or pandemic use

The side effects listed below have occurred with Pandemrix in clinical
studies in adults, including the elderly and in children aged from 3-9 years:

Very common:
........................

Headache

Tiredness

Pain, redness, swelling or a hard lump at the injection site

Fever

Aching muscles, joint pain

Common:
..................

Warmth, itching or bruising at the injection site

Increased sweating, shivering, flu-like symptoms

Swollen glands in the neck, armpit or groin

http://health.gsk.com/docs/UK_Pandemrix_PIL.pdf

http://health.gsk.com/hcp/H1N1Vaccine/how_to_use.

SheepLady

V.I.P. Member

Joined: May 31 2009
Location: PA
Status: Offline
Points: 302

Post Options

Post Reply

Quote SheepLady

Thanks(0)

Quote

Posted: October 24 2009 at 6:41am

Hi, Mary,

Have a question about the posting where Novartis claims the vaccine is inactivated. Do you think this means attenuated or is it a killed virus?

SheepLady

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 24 2009 at 12:30pm

hi... good question... same... inactivated or 'killed'

used so far... outside the US.

What Pandemrix contains

......................................

Active substance:

Split influenza virus, inactivated, containing antigen* equivalent to:

A/California/7/2009 (H1N1)v-like strain (X-179A)

3.75 micrograms** per 0.5 ml dose

* propagated in eggs

** expressed in microgram haemagglutinin

This vaccine complies with the WHO recommendation and EU decision

for the pandemic.

Adjuvant:

The vaccine contains an ‘adjuvant’ AS03 to stimulate a better response.

This adjuvant contains squalene (10.69 milligrams), DL-α-tocopherol

(11.86 milligrams) and polysorbate 80 (4.86 milligrams).

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 24 2009 at 12:56pm

Draw imaginary line down from each red arrow to compare years, 2009 slightly outside

(The little red line jutting up from the last curve..at 3rd arrow.)

As you can see... we are a bit outside the usual area as compared to years before...

Not alarming at this point.

Week 41
................

A/H1N1 is 3,378 cases..... out of 12,943 Influenza Like .... Cases tested

or...

"... in clinical laboratory specimens (29% of all specimens tested are positive for

influenza A and all of those subtyped are pandemic H1N1 2009 virus."

www.who.int/csr/disease/avian_influenza/en/index.htm

This means that all Respiratory illnes .... other than Influenza ...

is causing 71% of illness. so... what is it called?

> > >

During week 41, 6.9% of all deaths reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was above the epidemic threshold of 6.6% for week 41. Including week 41, P&I mortality has been above threshold for three consecutive weeks.

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 24 2009 at 4:05pm

There is a lot of illness out there... From what I see of the Sentinal Reports related by

CDC around the country ... the Emergency Declaration by the President is prudent.

The good news is... so far the Pneumonia and Influenza Mortality is not off the charts...

at this point. See Above...07- 2008 was worse....than 08-2009

........................................

and on the World Around us... this out from the CDC-

"... Although influenza activity is low in most countries in Europe, in Belgium, Israel,

the Netherlands, Norway, and parts of the United Kingdom consultation ILI/ARI rates

are above baseline levels.

... Rates of respiratory illness in Eastern Europe and Northern Asia are increasing but

are not yet at levels normally seen in an influenza season (baseline levels are not

defined in many countries of the area).

Of note, the proportion of cases in Asia that are related to seasonal influenza A(H3N2)

continue to decline globally as the proportion related to pandemic H1N1 2009 virus

increases.

Currently, only East Asia is reporting any significant numbers of influenza

A(H3N2) isolates.

In tropical areas of the world, rates of illness are generally declining, with a few

exceptions. Cuba, Colombia, and El Salvador are reporting increases in the tropical

region of the Americas.

In tropical Asia, of the countries that are reporting this week, all report decreases in

respiratory disease activity.

The temperate region of the southern hemisphere has no significant pandemic related

activity in the past week.

www.who.int/csr/disease/avian_influenza/en/index.htm

Mary008

.........................

coyote

Admin Group

Joined: April 25 2007
Location: United States
Status: Offline
Points: 2520

Post Options

Post Reply

Quote coyote

Thanks(0)

Quote

Posted: October 25 2009 at 3:26am

Hi Mary :>)

It's so far fairly quiet here in my neck of the woods. Will probably change very soon though. My best, here in the Catskill Mtn's, Coyote

Long time lurker since day one to Member.

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 25 2009 at 12:35pm

hi coyote...

Here also. No school closings ... nothing in the news.

You all stay well.

ages and numbers of people hospitalized from flu

(they are not accurate on.. if this is a running total? from begining of "flu season?"

NY Health Dept...

The number of people hospitalized with flu is currently low and appears to be increasing when compared to last week.

...................................

Downstate..Higher population... more Flu.

....................................................................

Flu-like Illness in NYS Hospital Emergency Departments as Percentage of Total Emergency Department Visits, by Region (year to date)

Age Groups for Hospitalized Flu Patients for week ending 10/17/09

http://www.health.state.ny.us/diseases/communicable/influenza/surveillance/2009-2010/

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 25 2009 at 8:50pm

Safe
........

Made The Same Was As Seasonal Flu Vaccines
.............................................................................

BUT

...clinical data at the time

when pandemic vaccines are first administered

will inevitably be

limited.

Further testing of safety

and effectiveness

will need to take place

after

administration of the vaccine has begun.

( That limited Clinical Data, and testing after administration of the vaccine,

makes for a warm and fuzzy trust in it. )

Safety of pandemic vaccines

Pandemic (H1N1) 2009 briefing note 6

6 AUGUST 2009 | GENEVA -- WHO is aware of some media reports that have expressed concern about the safety of vaccines for pandemic influenza. The public needs to be reassured that regulatory procedures in place for the licensing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality controls.

Vaccines are among the most important medical interventions for reducing illness and deaths during a pandemic. However, to have the greatest impact, pandemic vaccines need to be available quickly and in large quantities.

During the 1957 and 1968 pandemics, vaccines arrived too late to be used as an effective mitigation tool during the more severe phases of the pandemics. Influenza vaccines had not yet been developed when the 1918 pandemic swept around the world, eventually killing an estimated 50 million people.

In 2007, as part of preparedness for an influenza pandemic, WHO worked together with health officials, regulatory authorities, and vaccine manufacturers to explore a broad range of issues surrounding the regulatory approval of pandemic vaccines. [1]

Ways were sought

to shorten

the time between the emergence

of a pandemic virus

and the availability of safe and effective vaccines.

Different regulatory pathways were assessed,

and

precautions needed to ensure quality, safety, and effectiveness

were set out in detail.

Fast-track procedures for approval
...........................................................

Regulatory authorities have shown great flexibility in developing

procedures

for fast-tracking the approval and licensing of pandemic vaccines.

In some cases,

pandemic vaccines

are not regarded by regulatory authorities as entirely “new” vaccines,

as they build

on the technology

used to produce vaccines for seasonal influenza,

established procedures for testing and regulatory control,

and an extensive body of safety data.

In such cases, approval procedures are similar to those

applied to "strain changes"

made each year

when seasonal vaccines are modified

to match circulating viruses in the Northern and Southern Hemispheres.

Specific regulatory procedures have been devised

to expedite

the approval of pandemic vaccines.

In the USA, for example,

fewer data are required

when the manufacturer

already has

a licensed

influenza vaccine

and intends to use the same manufacturing process

for its pandemic vaccine.

In the European Union, the European Medicines Agency

uses a rolling review procedure

whereby manufacturers can submit sets of data

for regulatory review

as they become available,

without

having to wait

until all data

can be submitted together in a single formal application.

Also in Europe, some manufacturers have conducted advance studies

using a so-called

"mock-up"

vaccine.

Mock-up vaccines contain an active ingredient

for an influenza virus

that has not circulated

recently in human populations

and thus mimics

the novelty of a pandemic virus.

Such advance studies can greatly expedite regulatory approval.

Special safety concerns

Influenza vaccines have been used for more than 60 years and have an established record of safety in all age groups. While some serious adverse events have been reported, these have been rare.

Nonetheless, special safety issues will inevitably arise during a pandemic when vaccine is administered on a massive scale. For example, adverse events too rare to show up even in a large clinical trial may become apparent when very large numbers of people receive a pandemic vaccine.

Some adverse events will be coincidental- that is, associated in time with vaccine administration, yet not directly caused by the vaccine.

Genuine adverse events

directly caused by the vaccine may also occur,

but cannot be predicted

in advance.

Given the safety record of seasonal vaccines,

such events are expected to be rare.

Time constraints mean

that clinical data at the time when pandemic vaccines are first administered

will inevitably be limited.

Further testing of safety and effectiveness will need to take place

after administration of the vaccine has begun.

For these reasons,

WHO advises all countries

administering pandemic vaccines to conduct intensive monitoring for safety and efficacy,

and many countries have plans in place for doing so.

On the positive side,

mass vaccination campaigns can generate

significant safety data within a few weeks.

International sharing of data from such post-marketing surveillance will be vital in guiding risk-benefit assessments and determining whether changes in vaccination policies are needed. WHO has developed standardized protocols for data collection and reporting in real-time, and will communicate findings to the international community via its web site.

_________________________

[1] Regulatory preparedness for human pandemic influenza vaccines. Report of a WHO Expert Committee on Biological Standardization. Geneva: World Health Organization, 2007 [pdf 625kb]

source
http://www.who.int/csr/disease/swineflu/notes/h1n1_safety_vaccines_20090805/en/ind

ex.html

...................

Knowing that there is a lack of normal Clinical Data to go by is a Red Flag

pointing to the need for Government assistance for people who may be adversely affected

by Fast Tract Vaccines.

Mary008

V.I.P. Member

Joined: June 22 2009
Status: Offline
Points: 5769

Post Options

Post Reply

Quote Mary008

Thanks(0)

Quote

Posted: October 26 2009 at 10:11am

What Is Going On In The EU?

................................................

........................................................

........................................................................

H1N1 Pandemic Vaccine

.............................................

http://www.medicalnewstoday.com/articles/30483.php#

Excipients enable enhanced functionality,

besides helping to innovate drug formulations and extend patents.

Oh really...

Here is the innovative, patent extending list of ingredients-

excipients

Suspension vial:
Polysorbate 80
Octoxynol 10................................................ sperm killer?
Thiomersal (5 micrograms)
Sodium chloride (NaCl)
Disodium hydrogen phosphate (Na2HPO4)
Potassium dihydrogen phosphate (KH2PO4)
Potassium chloride (KCl)
Magnesium chloride (MgCl2)
Water for injections

Emulsion vial:
Sodium chloride (NaCl)
Disodium hydrogen phosphate (Na2HPO4)
Potassium dihydrogen phosphate (KH2PO4)
Potassium chloride (KCl)
Water for injections

Plus
.............

AS03 (for "Adjuvant System 03") is the trade name for a squalene-based immunologic

adjuvant used in various vaccine products by

GlaxoSmithKline (GSK). It is used, for example, in GSK's A/H1N1 pandemic flu vaccine Pandemrix.
A dose of AS03 adjuvant contains[1]
10.69 mg squalene
11.86 mg DL-α-tocopherol
4.86 mg polysorbate 80

and
............

Missing information ...

Antigen/content
Cell Line?
Nutrient?

There are currently no data available on the use of Pandemrix in pregnancy.

Excipients: the vaccine contains 5 micrograms thiomersal

This vaccine complies with the WHO recommendation and EU decision for the pandemic.

http://www.emea.europa.eu/humandocs/PDFs/EPAR/pandemrix/emea-combined-

h832en.pdf

.................

they give half the adult dose to a 6 mo old baby :O
.............................................................................................

Mary008

Members Profile